Stifel
Tracked across 8 events · 143 articles · First seen Jun 11, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Stifel is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Apr 16, 2026 · 7 articles
Business
Impact: Stifel served as the financial advisor for The Metals Royalty Company's direct listing on the Nasdaq.
Apr 08, 2026 · 6 articles
Business
Impact: Stifel Inc. is part of the syndicate of underwriters for Selkirk Copper Mines' private placement.
Apr 09, 2026 · 6 articles
Business
Impact: Stifel is one of the 16 banks participating in smaller roles for the SpaceX IPO.
Mar 27, 2026 · 61 articles
Business
Impact: Stifel acted as a bookrunner for the offering.
Apr 06, 2026 · 8 articles
Business
Impact: A Stifel analyst noted that the magnitude of dystrophin increase from PepGen's PGN-EDO51 drug was below expectations, contributing to negative market sentiment.
Jun 11, 2025 · 17 articles
Business
Form factor, a leading provider of test and measurement technologies for the IC life cycle, announced its participation in five upcoming investor conferences. These include the B. Riley 26th Annual Institutional Investor Conference, Toronto-Dominion Bank…
Impact: Stifel is hosting one of the investor conferences where Form factor will participate.
May 15, 2026 · 6 articles
Domestic
Dr. Marty Makary resigned as the head of the United States — Food and Drug Administration (FDA) after a turbulent 13-month tenure, marked by internal conflicts, mass layoffs, and a series of controversies. His departure…
Impact: An analyst from Stifel noted increased uncertainty regarding the United States — Food and Drug Administration's predictability under Marty Makary's leadership.
May 12, 2026 · 32 articles
NEWSDESK
Track Stifel live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard